Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q1 2022 13F Holders as of 31 Mar 2022

Security identity
Security type / class
Equity / Common Shares, No Par Value
Shares outstanding
28,495,649
Holder snapshot
Total 13F shares
54,297,692
Share change
-1,086,746
Total reported value
$81,004,102
Put/Call ratio
7.7%
Reported price per share
$1.49
Number of holders
76
Value change
-$2,234,275
Number of buys
22
Number of sells
41

Security key

68235C107

Report period

Q1 2022

Institutions

76

Top holders

10

OCX full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2022 Previous quarter: Q4 2021 Insight Molecular Diagnostics Inc. SEC filings Insight Molecular Diagnostics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BROADWOOD CAPITAL INC
13D/G signal
—
Evidence rows
50
Latest as of
31 Dec 2021
13F Lead comparable stake: 61% Showing 1-8 of 50 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD CAPITAL INC
13F
Company
13F
61%
$37,649,000
17,349,945 shares
 — 31 Dec 2021
PURA VIDA INVESTMENTS, LLC
13F
Company
13F
43%
$26,526,000
12,223,953 shares
 — 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
18%
$10,834,000
4,993,146 shares
 — 31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
14%
$8,454,000
3,895,736 shares
 — 31 Dec 2021
ORBIMED ADVISORS LLC
13F
Company
13F
12%
$7,582,000
3,493,800 shares
 — 31 Dec 2021
Defender Capital, LLC.
13F
Company
13F
7.8%
$4,811,000
2,216,800 shares
 — 31 Dec 2021
STATE STREET CORP
13F
Company
13F
4.9%
$3,006,000
1,385,461 shares
 — 31 Dec 2021
Nuveen Asset Management, LLC
13F
Company
13F
4.5%
$2,722,000
1,296,516 shares
 — 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
76
Shares
54,297,692
Rows loaded
76
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
82
Q1 2022 holders
76
Holder diff
-6
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .